O	0	6	Effect
O	7	9	of
B-intervention	10	21	information
O	22	27	about
O	28	31	the
O	32	40	benefits
O	41	44	and
O	45	50	harms
O	51	53	of
O	54	65	mammography
O	66	68	on
O	69	74	women
O	74	75	'
O	75	76	s
O	77	85	decision
O	86	92	making
O	92	93	:
O	94	97	The
O	98	105	InforMa
O	106	116	randomised
O	117	127	controlled
O	128	133	trial
O	133	134	.

O	135	137	In
B-location	138	143	Spain
O	143	144	,
O	145	150	women
O	151	158	invited
O	159	161	to
O	162	168	breast
O	169	178	screening
O	179	182	are
O	183	186	not
O	187	194	usually
O	195	203	informed
O	204	209	about
O	210	219	potential
O	220	225	harms
O	226	228	of
O	229	238	screening
O	238	239	.

O	240	243	The
O	244	253	objective
O	254	256	of
O	257	260	the
O	261	268	InforMa
O	269	274	study
O	275	277	is
O	278	280	to
O	281	287	assess
O	288	291	the
O	292	298	effect
O	299	301	of
O	302	311	receiving
O	312	323	information
O	324	329	about
O	330	333	the
O	334	342	benefits
O	343	346	and
O	347	352	harms
O	353	355	of
O	356	362	breast
O	363	372	screening
O	373	375	on
O	376	384	informed
O	385	391	choice
O	392	395	and
O	396	401	other
O	402	410	decision
O	410	411	-
O	411	417	making
O	418	426	outcomes
O	426	427	,
O	428	430	in
O	431	436	women
O	437	448	approaching
O	449	452	the
O	453	456	age
O	457	459	of
O	460	470	invitation
O	471	473	to
O	474	485	mammography
O	486	495	screening
O	495	496	.

O	497	500	Two
O	500	501	-
O	501	506	stage
O	507	517	randomised
O	518	528	controlled
O	529	534	trial
O	534	535	.

O	536	538	In
O	539	542	the
O	543	548	first
O	549	554	stage
O	554	555	,
O	556	558	40
O	559	569	elementary
O	570	581	territorial
O	582	587	units
O	588	590	of
O	591	594	the
O	595	601	public
O	602	612	healthcare
O	613	619	system
O	620	624	were
O	625	633	selected
O	634	637	and
O	638	648	randomised
O	649	651	to
O	652	664	intervention
O	665	667	or
O	668	675	control
O	675	676	.

O	677	679	In
O	680	683	the
O	684	690	second
O	691	696	stage
O	696	697	,
O	698	703	women
O	704	708	aged
B-age	709	711	49
I-age	711	712	-
I-age	712	714	50
I-age	715	720	years
O	721	725	were
O	726	734	randomly
O	735	743	selected
O	743	744	.

O	745	748	The
O	749	755	target
O	756	762	sample
O	763	767	size
O	768	771	was
B-total-participants	772	775	400
O	776	781	women
O	781	782	.

O	783	788	Women
O	789	791	in
O	792	795	the
O	796	808	intervention
O	809	812	arm
O	813	821	received
O	822	823	a
O	824	832	decision
O	833	836	aid
O	837	838	(
O	838	840	DA
O	840	841	)
O	842	846	with
O	847	855	detailed
O	856	867	information
O	868	870	on
O	871	874	the
O	875	883	benefits
O	884	887	and
O	888	893	harms
O	894	896	of
O	897	906	screening
O	906	907	.

O	908	913	Women
O	914	916	in
O	917	920	the
O	921	928	control
O	929	932	arm
O	933	941	received
O	942	943	a
B-control	944	952	standard
I-control	953	960	leaflet
O	961	965	that
O	966	969	did
O	970	973	not
O	974	981	mention
O	982	987	harms
O	988	991	and
O	992	1003	recommended
O	1004	1013	accepting
O	1014	1017	the
O	1018	1028	invitation
O	1029	1031	to
O	1032	1043	participate
O	1044	1046	in
O	1047	1050	the
O	1051	1057	Breast
O	1058	1064	Cancer
O	1065	1074	Screening
O	1075	1082	Program
O	1083	1084	(
O	1084	1088	BCSP
O	1088	1089	)
O	1089	1090	.

O	1091	1094	The
O	1095	1102	primary
O	1103	1110	outcome
O	1111	1114	was
B-outcome-Measure	1115	1123	informed
I-outcome-Measure	1124	1130	choice
O	1130	1131	,
O	1132	1139	defined
O	1140	1142	as
O	1143	1151	adequate
O	1152	1161	knowledge
O	1162	1165	and
O	1166	1176	intentions
O	1177	1187	consistent
O	1188	1192	with
O	1193	1202	attitudes
O	1202	1203	.

O	1204	1213	Secondary
O	1214	1222	outcomes
O	1223	1231	included
B-outcome-Measure	1232	1242	decisional
I-outcome-Measure	1243	1251	conflict
O	1251	1252	,
B-outcome-Measure	1253	1258	worry
I-outcome-Measure	1259	1264	about
I-outcome-Measure	1265	1271	breast
I-outcome-Measure	1272	1278	cancer
O	1278	1279	,
B-outcome-Measure	1280	1284	time
I-outcome-Measure	1285	1296	perspective
O	1296	1297	,
B-outcome-Measure	1298	1306	opinions
I-outcome-Measure	1307	1312	about
I-outcome-Measure	1313	1316	the
I-outcome-Measure	1317	1319	DA
I-outcome-Measure	1320	1322	or
I-outcome-Measure	1323	1326	the
I-outcome-Measure	1327	1334	leaflet
O	1334	1335	,
O	1336	1339	and
B-outcome-Measure	1340	1353	participation
I-outcome-Measure	1354	1356	in
I-outcome-Measure	1357	1360	the
I-outcome-Measure	1361	1365	BCSP
O	1365	1366	.

O	1367	1369	In
O	1370	1373	the
O	1374	1386	intervention
O	1387	1392	group
O	1392	1393	,
B-iv-bin-percent	1394	1396	23
I-iv-bin-percent	1396	1397	.
I-iv-bin-percent	1397	1398	2
I-iv-bin-percent	1398	1399	%
O	1400	1402	of
B-intervention-participants	1403	1406	203
O	1407	1412	women
B-outcome	1413	1417	made
I-outcome	1418	1420	an
I-outcome	1421	1429	informed
I-outcome	1430	1436	choice
O	1437	1445	compared
O	1446	1448	to
O	1449	1453	only
B-cv-bin-percent	1454	1455	0
I-cv-bin-percent	1455	1456	.
I-cv-bin-percent	1456	1457	5
I-cv-bin-percent	1457	1458	%
O	1459	1461	of
B-control-participants	1462	1465	197
O	1466	1471	women
O	1472	1474	in
O	1475	1478	the
O	1479	1486	control
O	1487	1492	group
O	1493	1494	(
O	1494	1495	p
O	1496	1497	<
O	1498	1499	0
O	1499	1500	.
O	1500	1503	001
O	1503	1504	)
O	1504	1505	.

B-outcome	1506	1515	Attitudes
I-outcome	1516	1519	and
I-outcome	1520	1530	intentions
O	1531	1535	were
O	1536	1543	similar
O	1544	1546	in
O	1547	1551	both
O	1552	1557	study
O	1558	1564	groups
O	1565	1569	with
O	1570	1571	a
O	1572	1576	high
O	1577	1586	frequency
O	1587	1589	of
O	1590	1595	women
O	1596	1605	intending
O	1606	1608	to
O	1609	1611	be
O	1612	1620	screened
O	1620	1621	,
B-iv-bin-percent	1622	1624	82
I-iv-bin-percent	1624	1625	.
I-iv-bin-percent	1625	1626	8
I-iv-bin-percent	1626	1627	%
O	1628	1630	vs
B-cv-bin-percent	1631	1633	82
I-cv-bin-percent	1633	1634	.
I-cv-bin-percent	1634	1635	2
I-cv-bin-percent	1635	1636	%
O	1637	1638	(
O	1638	1639	p
O	1640	1641	=
O	1642	1643	0
O	1643	1644	.
O	1644	1647	893
O	1647	1648	)
O	1648	1649	.

B-outcome	1650	1660	Decisional
I-outcome	1661	1669	conflict
O	1670	1673	was
O	1674	1687	significantly
O	1688	1693	lower
O	1694	1696	in
O	1697	1700	the
O	1701	1713	intervention
O	1714	1719	group
O	1719	1720	.

O	1721	1723	No
O	1724	1735	differences
O	1736	1740	were
O	1741	1749	observed
O	1750	1752	in
B-outcome	1753	1763	confidence
I-outcome	1764	1766	in
I-outcome	1767	1770	the
I-outcome	1771	1779	decision
I-outcome	1779	1780	,
I-outcome	1781	1788	anxiety
I-outcome	1788	1789	,
I-outcome	1790	1793	and
I-outcome	1794	1807	participation
I-outcome	1808	1810	in
I-outcome	1811	1815	BCSP
O	1815	1816	.

O	1817	1822	Women
O	1823	1825	in
O	1826	1831	Spain
O	1832	1836	lack
O	1837	1846	knowledge
O	1847	1849	on
O	1850	1853	the
O	1854	1862	benefits
O	1863	1866	and
O	1867	1872	harms
O	1873	1875	of
O	1876	1882	breast
O	1883	1892	screening
O	1892	1893	.

O	1894	1903	Providing
O	1904	1916	quantitative
O	1917	1928	information
O	1929	1931	on
O	1932	1940	benefits
O	1941	1944	and
O	1945	1950	harms
O	1951	1954	has
O	1955	1963	produced
O	1964	1965	a
O	1966	1978	considerable
O	1979	1987	increase
O	1988	1990	in
O	1991	2000	knowledge
O	2001	2004	and
O	2005	2013	informed
O	2014	2020	choice
O	2020	2021	,
O	2022	2026	with
O	2027	2028	a
O	2029	2033	high
O	2034	2044	acceptance
O	2045	2047	of
O	2048	2051	the
O	2052	2063	informative
O	2064	2073	materials
O	2073	2074	.

O	2075	2080	Trial
O	2081	2091	identifier
O	2092	2103	NCT03046004
O	2104	2106	at
O	2107	2121	ClinicalTrials
O	2121	2122	.
O	2122	2125	gov
O	2126	2134	registry
O	2134	2135	.

O	2136	2146	Registered
O	2147	2149	on
O	2150	2158	February
O	2159	2160	4
O	2161	2165	2017
O	2165	2166	.

O	2167	2172	Trial
O	2173	2177	name
O	2177	2178	:
O	2179	2186	InforMa
O	2187	2192	study
O	2192	2193	.
